This Biotech Stock Could Cure Your Portfolio's Pain

A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's ...

2 Healthcare Stocks to Buy Ahead of the New Year

These companies could innovate their way to success.

Astera Labs: Riding AI Sustains Growth Above Peers

Astera Labs (ALAB) stock stands out in AI data centers with 104% revenue growth and innovative tech. Read here for an ...
Investor's Business Daily on MSN

Stocks to watch: CRISPR Therapeutics sees relative strength rating rise to 82

CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...